離心分離市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、型號、應用、最終用戶、地區和競爭格局分類，2021-2031年）

全球離心機市場預計將從 2025 年的 87.5 億美元成長到 2031 年的 118.1 億美元，複合年成長率為 5.13%。

離心是一種利用離心力將溶液中的顆粒根據其不同的物理性質（例如尺寸、黏度和密度）進行分離的機械技術。該市場的成長主要受生物製藥產業（尤其是疫苗生產和藥物研發領域）對高效分離技術日益成長的需求所驅動。此外，血庫對成分分離的迫切需求以及這些系統在臨床診斷中日益廣泛的應用也促進了這一成長。根據國際藥品製造商協會聯合會（IFPMA）2024年發布的數據，“全球有超過12,700種藥品處於不同的研發階段”，這凸顯了蓬勃發展的研發環境正在推動實驗室分離設備的採購。

然而，先進離心系統高昂的購買和維護成本是阻礙市場成長的一大障礙。頻繁的轉子校準、昂貴的零件更換以及專業的維護技術，給小規模獨立實驗室和醫療機構帶來了沉重的經濟負擔，尤其是在預算有限的地區。這些費用可能會限制高速離心機和超速離心機的廣泛應用。

市場促進因素

慢性病和感染疾病率的不斷上升是全球離心機市場的主要驅動力，也因此催生了對更強大的科學研究和診斷能力的需求。隨著癌症和血液疾病等疾病的日益普遍，臨床檢查室和研究機構需要高性能離心系統來精確分離DNA、細胞物質和血液成分等生物樣本，這對於準確的診斷和治療策略至關重要。日益成長的疾病負擔直接導致了對可靠實驗室設備的需求增加，以滿足不斷成長的檢測量。美國癌症協會於2024年1月發布的《2024年癌症事實與數據》預測，美國新增癌症病例數將首次超過200萬例，凸顯了建立健全的診斷基礎設施的迫切需求。

同時，旨在發現新療法和疫苗的醫藥和生技研發活動的擴張也對市場產生了重大影響。離心機在這些研發流程中發揮至關重要的作用，包括蛋白質純化、細胞收集和活性藥物成分的分離。對個人化醫療和生物製藥的日益重視促使人們加大對實驗室技術的投資，以確保產量和純度。根據歐洲製藥工業協會聯合會（EFPIA）於2024年6月發布的《2024年製藥業數據概覽》，預計2023年歐洲以研發為驅動的生物製藥產業研發投入將達到500億歐元。此外，政府措施也支持這項成長。 2024年，英國政府承諾向生命科學創新製造基金撥款5.2億英鎊，以確保大規模投資並支持救命藥物的生產。

市場挑戰

先進離心系統高昂的購置成本和維護成本是限制全球市場成長的一大障礙。高性能設備，特別是用於基因組學和蛋白​​質組學研究的超高速離心機，需要大量的初始投資，這給中小型研究機構和獨立醫療機構的預算帶來了沉重負擔。除了購置價格外，定期轉子校準和專業技術服務以確保安全性和準確性的嚴格要求也增加了總擁有成本。這些持續的營運成本常常迫使採購部門推遲老舊設備的更換，從而延緩了支援市場擴張所需的更新周期。

醫療機構面臨的財務壓力加劇了這個問題，限制了可用於購買新設備的資金。美國醫院協會 (AHA) 在 2025 年的一份報告中指出，「94% 的醫療機構管理者預計會推遲設備升級以應對財務負擔。」這種財政保守主義直接影響離心機市場，降低了成本敏感地區新技術的採用率。因此，實驗室往往選擇延長現有設備的使用壽命，而不是投資新系統，這對整個產業的收入成長造成了顯著的拖累。

市場趨勢

生物製藥生產中一次性離心系統的日益普及正在從根本上改變下游工作流程。在生物製藥和細胞療法需求不斷成長的推動下，製造商正從傳統的不銹鋼設備轉向一次性技術，這些技術無需清洗驗證步驟，並顯著降低了批次間交叉污染的風險。這種轉變能夠加快多產品生產設施的換線速度，提高柔軟性，從而直接滿足產業對操作速度和無菌性的要求。根據賽多利斯於2025年2月發布的2024年度報告，生物製程解決方案部門的訂單以外匯匯率計算成長了12.7%，證實了市場對這些先進的一次性生產技術的需求正在復甦。

同時，企業淨零排放承諾和不斷上漲的營運成本正在加速向永續、節能的實驗室設備轉型。科研實驗室優先選用配備碳氫化合物冷卻系統、可減少摩擦的真空系統以及自動待機模式的離心機，以最大限度地減少閒置期間的電力消耗。這項轉變的驅動力來自國際社會為量化和認證實驗室設備的環境影響所做的努力，迫使製造商不斷創新，以降低碳足跡。 2025年1月，My Green Lab在其題為《進步之年：My Green Lab 2024年主要成果》的報告中指出，國際實驗室冷凍庫挑戰賽為參與機構節省了3180萬千瓦時的能源。這一數字凸顯了整個產業為提高關鍵設備（包括分離設備和冷凍系統）的能源效率所做的努力。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球離心機市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按產品（設備、配件）
  • 依型號類型（桌上型離心機、落地式離心機）
  • 按應用領域（臨床研究、生物製藥生產等）
  • 按最終用戶（醫院/血庫、生物技術/製藥實驗室、學術研究機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美離心機市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲離心機市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區離心機市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲離心機市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲離心機市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球離心機市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Agilent Technologies, Inc.
• QIAGEN NV
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Eppendorf SE
• Corning Incorporated
• Hanil Scientific Inc.
• Daihan Scientific Co., Ltd.
• DLAB Scientific Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Centrifugation Market is projected to grow from USD 8.75 Billion in 2025 to USD 11.81 Billion by 2031, reflecting a CAGR of 5.13%. Centrifugation is a mechanical technique that employs centrifugal force to isolate particles from a solution based on distinct physical characteristics such as size, viscosity, and density. This market is primarily driven by the expanding biopharmaceutical industry, particularly the rising need for effective separation technologies in vaccine production and drug discovery. This growth is further supported by the essential requirements of blood banks for component fractionation and the increasing use of these systems in clinical diagnostics. As noted by the 'International Federation of Pharmaceutical Manufacturers and Associations' in '2024', 'there were more than 12,700 medicines in various stages of development globally', a statistic that highlights the robust research environment stimulating the procurement of laboratory separation equipment.

However, a major obstacle potentially hindering market growth is the high capital and maintenance cost linked to advanced centrifugation systems. The need for frequent rotor calibration, expensive component replacements, and specialized technical maintenance places a significant financial strain on smaller independent laboratories and healthcare facilities, especially in budget-constrained regions. These expenses can limit the widespread adoption of high-speed centrifuges and ultracentrifuges.

Market Driver

The growing incidence of chronic and infectious diseases acts as a primary catalyst for the Global Centrifugation Market, creating a need for enhanced research and diagnostic capabilities. As rates of conditions such as cancer and blood disorders rise, clinical laboratories and research institutions require high-performance centrifugation systems to precisely separate biological samples, including DNA, cellular materials, and blood components, which are vital for accurate diagnosis and treatment strategies. This increasing disease burden directly correlates with the demand for reliable laboratory equipment to manage higher testing volumes. The American Cancer Society's 'Cancer Facts & Figures 2024', released in January 2024, projects that new cancer diagnoses in the United States will exceed 2 million for the first time, underscoring the critical need for robust diagnostic infrastructure.

At the same time, the market is significantly influenced by expanding pharmaceutical and biotechnology research and development (R&D) activities aimed at discovering novel therapeutics and vaccines. Centrifuges are indispensable in these R&D workflows, utilized for protein purification, cell harvesting, and the isolation of active pharmaceutical ingredients. The intensifying focus on personalized medicine and biologics has led to increased investment in laboratory technologies that ensure yield and purity. According to the European Federation of Pharmaceutical Industries and Associations' 'The Pharmaceutical Industry in Figures 2024' from June 2024, the research-based biopharmaceutical industry is estimated to have invested €50,000 million in R&D in Europe in 2023. Furthermore, government initiatives are reinforcing this growth; the UK Government announced a £520 million commitment in 2024 for the Life Sciences Innovative Manufacturing Fund to secure major investments and support the production of life-saving medicines.

Market Challenge

The significant capital and maintenance expenses associated with advanced centrifugation systems represent a major barrier to the growth of the global market. High-performance units, particularly ultracentrifuges used in genomic and proteomic research, require a substantial upfront investment that strains the budgets of small-to-medium-sized laboratories and independent healthcare facilities. Beyond the initial purchase price, the total cost of ownership is increased by the strict requirement for regular rotor calibration and specialized technical servicing to ensure safety and precision. These ongoing operational costs often force procurement departments to postpone upgrading aging machinery, thereby slowing the replacement cycle necessary for market expansion.

Financial pressures on healthcare providers further exacerbate this issue, limiting the funds available for new capital equipment. The 'American Hospital Association' reported in '2025' that '94% of health care administrators expect to delay equipment upgrades to manage financial strain'. This fiscal conservatism directly impacts the centrifugation market by reducing the adoption rate of newer technologies in cost-sensitive regions. Consequently, laboratories frequently opt to extend the lifespan of existing units rather than investing in modern systems, creating a measurable drag on overall industry revenue growth.

Market Trends

The increasing adoption of single-use centrifugation systems in biopharmaceutical manufacturing is fundamentally altering downstream processing workflows. As the demand for biologics and cell therapies grows, manufacturers are shifting away from traditional stainless-steel equipment to disposable technologies that eliminate cleaning validation steps and significantly reduce the risk of cross-contamination between batches. This transition enables faster changeovers and greater flexibility in multi-product facilities, directly addressing the industry's need for operational speed and sterility. According to Sartorius in February 2025, within the 'Annual Report 2024', the Bioprocess Solutions Division recorded a 12.7% increase in order intake in constant currencies, underscoring the recovering market demand for these advanced single-use manufacturing technologies.

Simultaneously, there is a decisive transition towards sustainable and energy-efficient laboratory equipment, driven by corporate net-zero pledges and rising operational costs. Laboratories are increasingly prioritizing centrifuges equipped with features such as hydrocarbon-based cooling, vacuum systems to reduce friction, and automatic standby modes to minimize electricity consumption during idle periods. This shift is supported by global initiatives that quantify and certify the environmental impact of research hardware, pushing manufacturers to innovate for lower carbon footprints. My Green Lab reported in 'A Year of Progress: My Green Lab's Key Achievements in 2024' in January 2025 that the International Laboratory Freezer Challenge resulted in participants saving 31.8 million kWh of energy, a metric that highlights the sector's broader commitment to reducing the energy intensity of essential devices including separation and cold-storage systems.

Key Market Players

• Agilent Technologies, Inc.
• QIAGEN N.V.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Eppendorf SE
• Corning Incorporated
• Hanil Scientific Inc.
• Daihan Scientific Co., Ltd.
• DLAB Scientific Co., Ltd.

Report Scope

In this report, the Global Centrifugation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Centrifugation Market, By Product

• Equipment
• Accessories

Centrifugation Market, By Model Type

• Benchtop Centrifuges
• Floor-Standing Centrifuges

Centrifugation Market, By Application

• Clinical Research
• Biotherapeutic Manufacturing
• Others

Centrifugation Market, By End-User

• Hospitals and Blood Banks
• Biotechnology and Pharmaceutical Laboratories
• Academic and Research Institutes
• Others

Centrifugation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Centrifugation Market.

Available Customizations:

Global Centrifugation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Centrifugation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Equipment, Accessories)
  • 5.2.2. By Model Type (Benchtop Centrifuges, Floor-Standing Centrifuges)
  • 5.2.3. By Application (Clinical Research, Biotherapeutic Manufacturing, Others)
  • 5.2.4. By End-User (Hospitals and Blood Banks, Biotechnology and Pharmaceutical Laboratories, Academic and Research Institutes, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Centrifugation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Model Type
  • 6.2.3. By Application
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Centrifugation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Model Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-User
  • 6.3.2. Canada Centrifugation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Model Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-User
  • 6.3.3. Mexico Centrifugation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Model Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-User

7. Europe Centrifugation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Model Type
  • 7.2.3. By Application
  • 7.2.4. By End-User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Centrifugation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Model Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-User
  • 7.3.2. France Centrifugation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Model Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-User
  • 7.3.3. United Kingdom Centrifugation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Model Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-User
  • 7.3.4. Italy Centrifugation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Model Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain Centrifugation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Model Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-User

8. Asia Pacific Centrifugation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Model Type
  • 8.2.3. By Application
  • 8.2.4. By End-User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Centrifugation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Model Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-User
  • 8.3.2. India Centrifugation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Model Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-User
  • 8.3.3. Japan Centrifugation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Model Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-User
  • 8.3.4. South Korea Centrifugation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Model Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End-User
  • 8.3.5. Australia Centrifugation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Model Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End-User

9. Middle East & Africa Centrifugation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Model Type
  • 9.2.3. By Application
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Centrifugation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Model Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-User
  • 9.3.2. UAE Centrifugation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Model Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-User
  • 9.3.3. South Africa Centrifugation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Model Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-User

10. South America Centrifugation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Model Type
  • 10.2.3. By Application
  • 10.2.4. By End-User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Centrifugation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Model Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End-User
  • 10.3.2. Colombia Centrifugation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Model Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End-User
  • 10.3.3. Argentina Centrifugation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Model Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Centrifugation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Agilent Technologies, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. QIAGEN N.V.
• 15.3. Bio-Rad Laboratories, Inc.
• 15.4. Thermo Fisher Scientific, Inc.
• 15.5. Danaher Corporation
• 15.6. Eppendorf SE
• 15.7. Corning Incorporated
• 15.8. Hanil Scientific Inc.
• 15.9. Daihan Scientific Co., Ltd.
• 15.10. DLAB Scientific Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer